The chemokine system: Tuning and shaping by regulation of receptor expression and coupling in polarized responses

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 11, 2002, Pages 972-982

  Locati, M ^a   Otero, K ^b   Schioppa, T ^b   Signorelli, P ^a   Perrier, P ^b   Baviera, S ^b   Sozzani, S ^b,c   Mantovani, A ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Chemokine; Chemokine receptor; Leukocyte recruitment; T lymphocyte subsets

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

COMPLEX FORMATION; COUPLING FACTOR; DENDRITIC CELL; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MOLECULAR CLONING; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVIEW; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINES, CC; DOWN-REGULATION; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 0036829150     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.02166.x     Document Type: Review

References (111)

1. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
2. Hedrick JA, Zlotnik A. Chemokines and lymphocyte biology. Curr Opin Immunol 1996;8:343-347.
3. Rollins BJ. Chemokines. Blood 1997;90:909-928.
4. Mantovani A. The chemokine system: Redundancy for robust outputs. Immunol Today 1999;20:254-257.
5. Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000;12:121-127.
6. Meltzer MS, Stevenson MM, Leonard EJ. Characterization of macrophage chemotaxis in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. Cancer Res 1977;37:721-725.
7. Bottazzi B, Polentarutti N, Acero R et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983;220:210-212.
8. Bottazzi B, Ghezzi P, Taraboletti G et al. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer 1985;36:167-173.
9. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-270.
10. Valente AJ, Fowler SR, Sprague EA, Kelley JL, Suenram CA, Schwartz CJ. Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am J Pathol 1984;117:409-417.
11. Zullo JN, Cochran BH, Huang AS, Stiles CD. Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 1985;43:793-800.
12. Rollins BJ, Morrison ED, Stiles CD. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA 1988;85:3738-3742.
13. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989;169:1449-1459.
14. Matsushima K, Larsen CG, Dubois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989;169:1485-1490.
15. Zachariae CO, Anderson AO, Thompson HL et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 1990;171:2177-2182.
16. Van Damme J, Decock B, Lenaerts JP et al. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur J Immunol 1989;19:2367-2373.
17. Graves DT, Jiang YL, Williamson MJ, Valente AJ. Identification of monocyte chemotactic activity produced by malignant cells. Science 1989;245:1490-1493.
18. Furutani Y, Nomura H, Notake M et al. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun 1989;159:248-255.
19. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulation blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989;244:487-493.
20. Bottazzi B, Colotta F, Sica A, Nobili N, Mantovani A. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer 1990;45:795-797.
21. Murphy PM, Baggiolini M, Charo IF et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145-176.
22. Mantovani A, Gray PA, Van Damme J, Sozzani S. Macrophage-derived chemokine. J Leukoc Biol 2000;68:400-404.
23. Fraticelli P, Sironi M, Bianchi G et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001;107:11731181.
24. Van Damme J, Struyf S, Wuyts A et al. The role of CD26/DPP IV in chemokine processing. Chem Immunol 1999;72:42-56.
25. Demeester I, Korom S, Van Damme J, Scharpé S. CD26, let it cut or cut it down. Immunol Today 1999;20:367-375.
26. Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev 1998;161:55-70.
27. Lambeir AM, Proost P, Durinx C et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 2001;276:29839-29845.
28. Struyf S, Menten P, Lenaerts JP et al. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur J Immunol 2001;31:2170-2178.
29. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
30. Sica A, Saccani A, Borsatti A et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 1997;185:969-974.
31. Penton-Rol G, Cota M, Polentarutti N et al. Upregulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones. J Immunol 1999;163:3524-3529.
32. Sozzani S, Ghezzi S, Iannolo G et al. Interleukin-10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 1998;187:439-444.
33. Bonecchi R, Polentarutti N, Luini W et al. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by interferon gamma in human neutrophils. J Immunol 1999;162:474-479.
34. D'Amico G, Frascaroli G, Bianchi G et al. Uncoupling of inflammatory chemokine receptors by IL-10: Generation of functional decoys. Nature Immunol 2000;1:387-391.
35. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors, a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 2001;22:328-336.
36. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
37. Penna G, Sozzani S, Adorini L. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001;167:1862-1866.
38. Power CA, Church DJ, Meyer A et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells. J Exp Med 1997;186:825-835.
39. Yang D, Chen Q, Chertov O, Oppenheim JJ. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 2000;68:9-14.
40. Cook DN, Prosser DM, Forster R et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis and immune responses in mucosal tissue. Immunity 2000;12:495-503.
41. Samson M, Edinger AL, Stordeur P et al. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 1998;28:1689-1700.
42. Cyster JG. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999;189:447-450.
43. Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A. The chemokine receptor switch paradigm and dendritic cell migration: Its significance in tumor tissues. Immunol Rev 2000;177:141-149.
44. Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998;28:2760-2769.
45. Vulcano M, Albanesi C, Stoppacciaro A et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001;31:812-822.
46. Kanazawa N, Nakamura T, Tashiro K et al. Fractalkine and macrophagederived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur J Immunol 1999;29:1925-1932.
47. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000;1:298-304.
48. Vissers JL, Hartgers FC, Lindhout E, Figdor CG, Adema GJ. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur J Immunol 2001;31:1544-1549.
49. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
50. Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A. The chemokine receptor switch paradigm and dendritic cell migration: Its significance in tumor tissues. Immunol Rev 2000;177:141-149.
51. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol 2001;2:102-107.
52. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
53. Gunn MD, Kyuwa S, Tam C et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-460.
54. Förster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
55. Morales J, Homey B, Vicari AP et al. CTACK, a skin-associated chemokine that preferentially attracts skin- homing memory T cells. Proc Natl Acad Sci USA 1999;96:14470-14475.
56. Campbell JJ, Haraldsen G, Pan J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400:776-780.
57. Annunziato F, Cosmi L, Galli G et al. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol 1999;65:691-699.
58. Romagnani P, Annunziato F, Piccinni MP, Maggi E, Romagnani S. Cytokines and chemokines in T lymphopoiesis and T-cell effector function. Immunol Today 2000;21:416-418.
59. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 2000;30:2972-2979.
60. Panina-Bordignon P, Papi A, Mariani M et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001;107:1357-1364.
61. + dendritic cells. Nature Immunol 2000;1:83-87.
62. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000;404:407-411.
63. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001;357:539-545.
64. Negus RP, Stamp GW, Relf MG et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 1995;95:2391-2396.
65. Luboshits G, Shina S, Kaplan O et al. Elevated expression of the CC chemokine RANTES in advanced breast carcinoma. Cancer Res 1999;59:4681-4687.
66. Riethdorf L, Riethdorf S, Gutzlaff K, Prall F, Loning T. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am J Pathol 1996;149:1469-1476.
67. Sciacca FL, Stürzl M, Bussolino F et al. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol 1994;153:4816-4825.
68. Luciani MG, Stoppacciaro A, Peri G, Mantovani A, Ruco LP. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours. Mol Pathol 1998;51:273-276.
69. Valkovic T, Lucin K, Krstulja M, Dobi-Babic R, Jonjic N. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract 1998;194:335-340.
70. Van Den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999;154:1685-1691.
71. Cossman J, Annunziata CM, Barash S et al. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999;94:411-416.
72. Jundt F, Anagnostopoulos I, Bommert K et al. Hodgkin/ReedSternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999;94:2065-2071.
73. Mazzucchelli L, Blaser A, Kappeler A et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999;104:R49-R54.
74. Choi C, Xu X, Oh JW et al. Fasinduced expression of chemokines in human glioma cells: Involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res 2001;61:3084-3091.
75. Hess S, Smola H, Sandaradura DE Silva U et al. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractant protein-1 production. J Immunol 2000;165:1939-1948.
76. Sica A, Saccani A, Bottazzi B et al. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J Immunol 2000;164:733-738.
77. Sica A, Saccani A, Bottazzi B et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-kB activation in tumor-associated macrophages. J Immunol 2000;164:762-767.
78. Maeda H, Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumorbearing mice. J Immunol 1996;156:73-78.
79. Kim J, Modlin RL, Moy RL et al. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 1995;155:2240-2247.
80. Sozzani S, Luini W, Bianchi G et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 1998;92:4036-4039.
81. Huang M, Wang J, Lee P et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995;55:3847-3853.
82. Yang TY, Chen SC, Leach MW et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 2000;191:445-454.
83. Cesarman E, Mesri EA, Gershengorn MC. Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? J Exp Med 2000;191:417-422.
84. Weber KS, Grone HJ, Rocken M et al. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol 2001;31:2458-2466.
85. Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick A. The Kaposi's sarcoma-related Herpes virus (KSHV) -encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J Exp Med 1999;189:1993-1998.
86. Stine JT, Wood C, Hill M et al. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts Th2 cells. Blood 2000;95:1151-1157.
87. Snyderman R, Cianciolo GJ. Immunosuppressive activity of the retroviral envelope protein P15E and its possible relationship to neoplasia. Immunol Today 1984;5:240-244.
88. Rutledge BJ, Rayburn H, Rosenberg R et al. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995;155:4838-4843.
89. Opdenakker G, Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today 1992;13:463-464.
90. Wang JM, Chertov O, Proost P et al. Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: Induction of migration and NFκB activation. Int J Cancer 1998;75:900-907.
91. Prest SJ, Rees RC, Murdoch C et al. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin Exp Metastasis 1999;17:389-396.
92. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
93. Wang JM, Taraboletti G, Matsushima K, Van Damme J, Mantovani A. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem Biophys Res Commun 1990;169:165-170.
94. Haghnegahdar HJ, Wang D, Strieter RM, Burdick MD, Nanney LB et al. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol 2000;67:53-62.
95. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54:3242-3247.
96. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR. Epithelial cancer cell migration: A role for chemokine receptors? Cancer Res 2001;61:4961-4965.
97. Schutyser E, Struyf S, Proost P et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/PARC in ovarian carcinoma. J Immunol in press.
98. Nesbit M, Schaider H, Miller TH, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001;166:6483-6490.
99. Nokihara H, Yanagawa H, Nishioka Y et al. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res 2000;60:7002-7007.
100. Fioretti F, Fradelizi D, Stoppacciaro A et al. Reduced tumorigenicity and augmented leukocyte infiltration after MCP-3 gene transfer: Perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J Immunol 1998;161:342-346.
101. Vicari AP, Ait-Yahia S, Chemin K, Mueller A, Zlotnik A, Caux C. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J Immunol 2000;165:1992-2000.
102. Nomura T, Hasegawa H, Kohno M, Sasaki M, Fujita S. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes. Int J Cancer 2001;91:597-606.
103. Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ et al. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: Augmentation of dendritic cell-based immunotherapy. Cancer Res 2001;61:2062-2070.
104. Balentien E, Mufson BE, Shattuck RL, Derynck R, Richmond A. Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 1991;6:1115-1124.
105. Sodhi A, Montaner S, Patel V et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor lalpha. Cancer Res 2000;60:4873-4880.
106. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-2428.
107. Bandeira-Melo C, Bozza PT, Diaz BL et al. Cutting edge: Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol 2000;164:2267-2271.
108. Braun MC, Lahey E, Kelsall BL. Selective suppression of IL-12 production by chemoattractants. J Immunol 2000;164:3009-3017.
109. Locati M, Deuschle U, Massardi ML, Martinez FO et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocyles. J Immunol 2002;168:3557-3562.
110. Fischer FR, Luo Y, Luo M, Santambrogio L, Dorf ME. RANTES-induced chemokine cascade in dendritic cells. J Immunol 2001;167:1637-1643.
111. Mantovani A, Dinarello C, Ghezzi P. Pharmacology of Cytokines. Oxford, UK: Oxford University Press 2000.